$VRAYQ
ViewRay Inc

2018 Q4 Form 10-Q Financial Statement

#000156459018028764 Filed on November 09, 2018

View on sec.gov

Income Statement

Concept 2018 Q4 2018 Q3 2017 Q4
Revenue $20.66M $17.67M $19.92M
YoY Change 3.71% 44.84% 23.5%
Cost Of Revenue $20.06M $17.30M $15.63M
YoY Change 28.34% 69.43% -9.6%
Gross Profit $600.0K $364.0K $4.290M
YoY Change -86.01% -81.66% -466.67%
Gross Profit Margin 2.9% 2.06% 21.54%
Selling, General & Admin $18.08M $20.11M $12.22M
YoY Change 47.95% 100.85% 76.59%
% of Gross Profit 3013.33% 5523.35% 284.85%
Research & Development $4.010M $4.350M $4.930M
YoY Change -18.66% 20.17% 102.88%
% of Gross Profit 668.33% 1195.05% 114.92%
Depreciation & Amortization $940.0K $900.0K $630.0K
YoY Change 49.21% 59.29% 65.79%
% of Gross Profit 156.67% 247.25% 14.69%
Operating Expenses $22.10M $24.45M $17.15M
YoY Change 28.86% 79.42% 83.62%
Operating Profit -$21.50M -$24.09M -$12.86M
YoY Change 67.19% 106.89% 22.36%
Interest Expense -$1.940M $1.974M -$1.870M
YoY Change 3.74% 7.11% 4.47%
% of Operating Profit
Other Income/Expense, Net $6.700M -$6.792M -$9.920M
YoY Change -167.54% -399.34% -868.99%
Pretax Income -$16.74M -$32.85M -$24.65M
YoY Change -32.09% 192.9% 123.89%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$16.74M -$32.85M -$24.65M
YoY Change -32.09% 192.9% 123.89%
Net Earnings / Revenue -81.03% -185.96% -123.74%
Basic Earnings Per Share
Diluted Earnings Per Share -$174.5K -$386.8K -$375.5K
COMMON SHARES
Basic Shares Outstanding 95.73M
Diluted Shares Outstanding

Balance Sheet

Concept 2018 Q4 2018 Q3 2017 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $167.4M $201.5M $57.40M
YoY Change 191.64% 485.76% 304.23%
Cash & Equivalents $167.4M $201.5M $57.39M
Short-Term Investments
Other Short-Term Assets $15.70M $17.10M $18.60M
YoY Change -15.59% 10.32% 169.57%
Inventory $49.46M $40.55M $19.38M
Prepaid Expenses
Receivables $36.87M $22.68M $20.33M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $277.7M $287.4M $122.7M
YoY Change 126.33% 280.68% 241.76%
LONG-TERM ASSETS
Property, Plant & Equipment $13.96M $13.45M $11.56M
YoY Change 20.7% 19.04% -0.31%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $1.395M $1.185M $235.0K
YoY Change 493.62% -1.25% -80.42%
Total Long-Term Assets $17.29M $16.02M $13.02M
YoY Change 32.76% 27.13% 0.93%
TOTAL ASSETS
Total Short-Term Assets $277.7M $287.4M $122.7M
Total Long-Term Assets $17.29M $16.02M $13.02M
Total Assets $295.0M $303.4M $135.7M
YoY Change 117.35% 244.42% 178.1%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $10.21M $6.964M $11.01M
YoY Change -7.33% 2.41% 120.28%
Accrued Expenses $9.983M $13.88M $7.207M
YoY Change 38.52% 54.22% 14.4%
Deferred Revenue $13.73M $20.15M
YoY Change -31.86%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $53.89M $44.40M $56.20M
YoY Change -4.11% -6.72% 50.96%
LONG-TERM LIABILITIES
Long-Term Debt $55.36M $44.65M $44.50M
YoY Change 24.4% 0.33% 0.48%
Other Long-Term Liabilities $820.0K $9.854M $7.370M
YoY Change -88.87% -56.4% -32.39%
Total Long-Term Liabilities $56.18M $54.50M $51.87M
YoY Change 8.31% -18.77% 17.12%
TOTAL LIABILITIES
Total Short-Term Liabilities $53.89M $44.40M $56.20M
Total Long-Term Liabilities $56.18M $54.50M $51.87M
Total Liabilities $127.7M $126.1M $133.7M
YoY Change -4.53% 9.92% 64.04%
SHAREHOLDERS EQUITY
Retained Earnings -$399.0M -$382.2M -$319.9M
YoY Change 24.74%
Common Stock $566.3M $559.6M $321.8M
YoY Change 75.95%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $167.3M $177.4M $1.987M
YoY Change
Total Liabilities & Shareholders Equity $295.0M $303.4M $135.7M
YoY Change 117.35% 244.42% 178.1%

Cashflow Statement

Concept 2018 Q4 2018 Q3 2017 Q4
OPERATING ACTIVITIES
Net Income -$16.74M -$32.85M -$24.65M
YoY Change -32.09% 192.9% 123.89%
Depreciation, Depletion And Amortization $940.0K $900.0K $630.0K
YoY Change 49.21% 59.29% 65.79%
Cash From Operating Activities -$44.76M -$28.59M -$26.36M
YoY Change 69.8% 44.32% 29188.89%
INVESTING ACTIVITIES
Capital Expenditures -$880.0K -$530.0K -$1.040M
YoY Change -15.38% 55.88% 188.89%
Acquisitions
YoY Change
Other Investing Activities $0.00
YoY Change
Cash From Investing Activities -$880.0K -$530.0K -$1.040M
YoY Change -15.38% 55.88% 188.89%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 12.07M 164.7M 50.38M
YoY Change -76.04% 25639.06% 125850.0%
NET CHANGE
Cash From Operating Activities -44.76M -28.59M -26.36M
Cash From Investing Activities -880.0K -530.0K -1.040M
Cash From Financing Activities 12.07M 164.7M 50.38M
Net Change In Cash -33.57M 135.6M 22.98M
YoY Change -246.08% -795.08% -5704.88%
FREE CASH FLOW
Cash From Operating Activities -$44.76M -$28.59M -$26.36M
Capital Expenditures -$880.0K -$530.0K -$1.040M
Free Cash Flow -$43.88M -$28.06M -$25.32M
YoY Change 73.3% 44.12% -9477.78%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2018
dei Entity Ex Transition Period
EntityExTransitionPeriod
true
dei Entity Small Business
EntitySmallBusiness
true
CY2018Q3 us-gaap Customer Deposits Current
CustomerDepositsCurrent
12243000
CY2018Q3 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
11315000
CY2018Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
95730214
CY2018Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
0
CY2018Q3 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
21962000
CY2017Q4 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
22420000
CY2018Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
9854000
CY2018Q3 us-gaap Liabilities
Liabilities
126073000
CY2018Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0
CY2018Q3 us-gaap Common Stock Value
CommonStockValue
941000
CY2018Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
558656000
CY2018Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-382237000
CY2018Q3 us-gaap Stockholders Equity
StockholdersEquity
177360000
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2018Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
22677000
CY2018Q3 us-gaap Inventory Net
InventoryNet
40547000
CY2018Q3 us-gaap Advances On Inventory Purchases
AdvancesOnInventoryPurchases
5565000
CY2018Q3 us-gaap Deferred Costs Current
DeferredCostsCurrent
10909000
CY2018Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
6174000
CY2018Q3 us-gaap Assets Current
AssetsCurrent
287415000
CY2018Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
13452000
CY2018Q3 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
1381000
CY2018Q3 us-gaap Assets
Assets
303433000
CY2018Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
201543000
CY2018Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1185000
CY2017Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
235000
CY2018Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
6964000
CY2018Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
13880000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
22116000
CY2017Q3 us-gaap Operating Expenses
OperatingExpenses
13628000
us-gaap Operating Expenses
OperatingExpenses
59600000
CY2018Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-24088000
CY2017Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-11643000
us-gaap Operating Income Loss
OperatingIncomeLoss
-53597000
CY2018Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
2000
CY2017Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2017Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2017Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
67653974
CY2017Q4 us-gaap Assets
Assets
135711000
CY2017Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
321174000
CY2017Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
11014000
CY2017Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-319853000
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
1987000
CY2017Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
7207000
CY2017Q4 us-gaap Customer Deposits Current
CustomerDepositsCurrent
17820000
CY2017Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
135711000
CY2017Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2017Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
20151000
CY2017Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2017Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
3238000
CY2017Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2017Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
44504000
CY2017Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
7370000
CY2017Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000
CY2017Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0
CY2017Q4 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2017Q4 us-gaap Common Stock Value
CommonStockValue
666000
CY2018Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
17302000
CY2018Q3 us-gaap Gross Profit
GrossProfit
364000
CY2018Q3 us-gaap Interest Expense
InterestExpense
1974000
CY2018Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
17666000
CY2018Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-6792000
CY2018Q3 us-gaap Operating Expenses
OperatingExpenses
24452000
CY2018Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-32852000
CY2018Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2018Q3 us-gaap Net Income Loss
NetIncomeLoss
-32852000
CY2018Q3 vray Amortization Of Beneficial Conversion Feature
AmortizationOfBeneficialConversionFeature
0
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
247000
CY2018Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
202924000
CY2017Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
35556000
CY2018Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.39
CY2018Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
84920996
CY2017Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
67653974
CY2018Q3 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
5206000
CY2018Q3 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2018Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
44649000
CY2017Q4 us-gaap Liabilities
Liabilities
133724000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
60299000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
14122000
CY2017Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
10212000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
277000
CY2018Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
303433000
CY2018Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2018Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2018Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2018Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2018Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2018Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000
CY2018Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
95195872
CY2018Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
95195872
CY2017Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
12197000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
54296000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
12080000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
9781000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
10024000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
5453000
CY2017Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
7502000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
37070000
us-gaap Operating Expenses
OperatingExpenses
37350000
us-gaap Operating Income Loss
OperatingIncomeLoss
-35308000
CY2017Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
1000
us-gaap Investment Income Interest
InvestmentIncomeInterest
6000
us-gaap Investment Income Interest
InvestmentIncomeInterest
3000
CY2017Q3 us-gaap Interest Expense
InterestExpense
1843000
us-gaap Interest Expense
InterestExpense
5758000
us-gaap Interest Expense
InterestExpense
5372000
CY2017Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
2269000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-307000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-6853000
CY2017Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-11216000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-59656000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-47530000
CY2017Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2017Q3 us-gaap Net Income Loss
NetIncomeLoss
-11216000
us-gaap Net Income Loss
NetIncomeLoss
-59656000
us-gaap Net Income Loss
NetIncomeLoss
-47530000
CY2017Q3 vray Amortization Of Beneficial Conversion Feature
AmortizationOfBeneficialConversionFeature
0
vray Amortization Of Beneficial Conversion Feature
AmortizationOfBeneficialConversionFeature
2728000
vray Amortization Of Beneficial Conversion Feature
AmortizationOfBeneficialConversionFeature
0
CY2018Q3 vray Net Income Loss Available To Common Stock Holders Basic And Diluted
NetIncomeLossAvailableToCommonStockHoldersBasicAndDiluted
-32852000
CY2017Q3 vray Net Income Loss Available To Common Stock Holders Basic And Diluted
NetIncomeLossAvailableToCommonStockHoldersBasicAndDiluted
-11216000
vray Net Income Loss Available To Common Stock Holders Basic And Diluted
NetIncomeLossAvailableToCommonStockHoldersBasicAndDiluted
-62384000
vray Net Income Loss Available To Common Stock Holders Basic And Diluted
NetIncomeLossAvailableToCommonStockHoldersBasicAndDiluted
-47530000
CY2017Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.19
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.82
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.85
CY2017Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
59061149
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
76185346
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
56064562
us-gaap Depreciation And Amortization
DepreciationAndAmortization
2561000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2766000
CY2017Q2 vray Line Of Credit Facility Additional Borrowing Capacity
LineOfCreditFacilityAdditionalBorrowingCapacity
15000000
CY2017Q2 vray Debt Instrument Existing Capacity Extended Expiration Date
DebtInstrumentExistingCapacityExtendedExpirationDate
2017-06-30
CY2016Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
2723000
us-gaap Accretion Expense Including Asset Retirement Obligations
AccretionExpenseIncludingAssetRetirementObligations
26000
CY2017Q2 vray Change In Line Of Credit Facility Commitment Fee Percentage
ChangeInLineOfCreditFacilityCommitmentFeePercentage
0.0175
CY2018Q3 us-gaap Purchase Obligation
PurchaseObligation
0
us-gaap Depreciation And Amortization
DepreciationAndAmortization
1574000
us-gaap Share Based Compensation
ShareBasedCompensation
10052000
us-gaap Share Based Compensation
ShareBasedCompensation
2766000
us-gaap Accretion Expense Including Asset Retirement Obligations
AccretionExpenseIncludingAssetRetirementObligations
29000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-116000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
6739000
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-1000
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-9000
us-gaap Inventory Write Down
InventoryWriteDown
0
us-gaap Inventory Write Down
InventoryWriteDown
647000
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
2703000
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
2453000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
2351000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-3158000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
22412000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
11143000
us-gaap Increase Decrease In Deposits Outstanding
IncreaseDecreaseInDepositsOutstanding
-1478000
us-gaap Increase Decrease In Deposits Outstanding
IncreaseDecreaseInDepositsOutstanding
3593000
us-gaap Increase Decrease In Deferred Charges
IncreaseDecreaseInDeferredCharges
-2327000
us-gaap Increase Decrease In Deferred Charges
IncreaseDecreaseInDeferredCharges
6481000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
2262000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
2124000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-4067000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
2108000
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
6732000
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
2519000
us-gaap Increase Decrease In Deferred Revenue And Customer Advances And Deposits
IncreaseDecreaseInDeferredRevenueAndCustomerAdvancesAndDeposits
-12445000
us-gaap Increase Decrease In Deferred Revenue And Customer Advances And Deposits
IncreaseDecreaseInDeferredRevenueAndCustomerAdvancesAndDeposits
5175000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-77429000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-43694000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2814000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1117000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2814000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1117000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
3571000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
224635000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
65026000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
144392000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
20215000
CY2017Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
58532000
CY2016Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
15341000
us-gaap Interest Paid Net
InterestPaidNet
3055000
us-gaap Interest Paid Net
InterestPaidNet
2919000
us-gaap Income Taxes Paid
IncomeTaxesPaid
0
us-gaap Income Taxes Paid
IncomeTaxesPaid
25000
vray Transfer Of Inventory And Deferred Cost Of Revenue To Property And Equipment
TransferOfInventoryAndDeferredCostOfRevenueToPropertyAndEquipment
1700000
vray Transfer Of Inventory And Deferred Cost Of Revenue To Property And Equipment
TransferOfInventoryAndDeferredCostOfRevenueToPropertyAndEquipment
125000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
129000
vray Fair Value Of Common Stock Warrants Reclassed From Liability To Additional Paid In Capital Upon Exercise
FairValueOfCommonStockWarrantsReclassedFromLiabilityToAdditionalPaidInCapitalUponExercise
342000
vray Fair Value Of Common Stock Warrants Reclassed From Liability To Additional Paid In Capital Upon Exercise
FairValueOfCommonStockWarrantsReclassedFromLiabilityToAdditionalPaidInCapitalUponExercise
0
CY2018Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
39509000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
3.18
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
2900000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
1800000
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.669
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.021
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.000
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
0
CY2018Q3 us-gaap Accounts Receivable Net Noncurrent
AccountsReceivableNetNoncurrent
400000
CY2017Q4 us-gaap Accounts Receivable Net Noncurrent
AccountsReceivableNetNoncurrent
0
vray Long Term Trade Credit Maintenance Services Term
LongTermTradeCreditMaintenanceServicesTerm
P1Y
CY2018Q3 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
0
CY2017Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
0
CY2018Q3 us-gaap Deferred Revenue Revenue Recognized1
DeferredRevenueRevenueRecognized1
12200000
us-gaap Deferred Revenue Revenue Recognized1
DeferredRevenueRevenueRecognized1
18300000
CY2017Q3 us-gaap Deferred Revenue Revenue Recognized1
DeferredRevenueRevenueRecognized1
9000000
us-gaap Deferred Revenue Revenue Recognized1
DeferredRevenueRevenueRecognized1
5800000
CY2018Q3 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
16245000
CY2018Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
30268000
CY2017Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
25898000
CY2018Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
16816000
CY2017Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
14334000
CY2018Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
906000
CY2017Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
565000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2500000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1600000
CY2018Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
5951000
CY2017Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
3944000
CY2018Q3 vray Accrued Payable
AccruedPayable
2642000
CY2017Q4 vray Accrued Payable
AccruedPayable
2671000
CY2018Q3 us-gaap Taxes Payable Current
TaxesPayableCurrent
4733000
CY2017Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
149000
CY2018Q3 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
498000
CY2017Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
322000
CY2017Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
121000
CY2018Q3 us-gaap Deferred Revenue
DeferredRevenue
16521000
CY2017Q4 us-gaap Deferred Revenue
DeferredRevenue
23389000
CY2018Q3 vray Accrued Interest Noncurrent
AccruedInterestNoncurrent
8777000
CY2017Q4 vray Accrued Interest Noncurrent
AccruedInterestNoncurrent
6218000
CY2018Q3 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
492000
CY2017Q4 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
167000
CY2018Q3 us-gaap Other Sundry Liabilities Noncurrent
OtherSundryLiabilitiesNoncurrent
585000
CY2017Q4 us-gaap Other Sundry Liabilities Noncurrent
OtherSundryLiabilitiesNoncurrent
985000
CY2017Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
22420000
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
116000
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
-6739000
CY2018Q3 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
21962000
CY2017Q3 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
12835000
CY2015Q2 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
50000000
CY2015Q2 us-gaap Line Of Credit Facility Current Borrowing Capacity
LineOfCreditFacilityCurrentBorrowingCapacity
30000000
CY2016Q2 us-gaap Line Of Credit Facility Remaining Borrowing Capacity
LineOfCreditFacilityRemainingBorrowingCapacity
20000000
CY2015Q2 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
30000000
us-gaap Debt Instrument Maturity Date
DebtInstrumentMaturityDate
2020-06-30
vray Interest Payment End Date
InterestPaymentEndDate
2020-03-31
us-gaap Debt Instrument Frequency Of Periodic Payment
DebtInstrumentFrequencyOfPeriodicPayment
quarterly
vray Debt Instrument Interest Payment Period
DebtInstrumentInterestPaymentPeriod
P3Y
CY2015Q2 us-gaap Debt Instrument Interest Rate Stated Percentage
DebtInstrumentInterestRateStatedPercentage
0.125
CY2015Q2 vray Debt Instrument Cash Interest Rate Percentage
DebtInstrumentCashInterestRatePercentage
0.08
CY2015Q2 vray Deferred Payment In Kind Interest Rate
DeferredPaymentInKindInterestRate
0.045
CY2015Q2 us-gaap Line Of Credit Facility Commitment Fee Percentage
LineOfCreditFacilityCommitmentFeePercentage
0.07
vray Term Loan First Amendment Description
TermLoanFirstAmendmentDescription
In March 2016, the Company amended the agreement with regard to the conditions for borrowing the remaining $20.0 million under the CRG Term Loan if certain product and service revenue amounts were achieved.
CY2016Q1 us-gaap Line Of Credit Facility Remaining Borrowing Capacity
LineOfCreditFacilityRemainingBorrowingCapacity
20000000
CY2016Q2 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
15000000
vray Term Loan Second Third And Fourth Amendment Description
TermLoanSecondThirdAndFourthAmendmentDescription
In April and October 2017, and in February 2018, the Company executed three amendments, which allowed the Company to borrow the remaining $5.0 million through June 30, 2017, included an additional $15.0 million borrowing capacity available through December 31, 2017, extended the interest-only and payment in-kind period, decreased the combined 2016 and 2017 revenue covenant, and increased the facility fee by 1.75%.
CY2017Q2 us-gaap Line Of Credit Facility Remaining Borrowing Capacity
LineOfCreditFacilityRemainingBorrowingCapacity
5000000
CY2017Q2 vray Debt Instrument Additional Capacity Extended Expiration Date
DebtInstrumentAdditionalCapacityExtendedExpirationDate
2017-12-31
CY2018Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
6.06
CY2017 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y4M24D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y3M18D
CY2018Q3 vray Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested And Unreleased
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndUnreleased
130889
CY2017Q4 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
0
CY2018Q3 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
45000000
CY2018Q3 vray Deferred Payment In Kind Interest
DeferredPaymentInKindInterest
6500000
CY2018Q3 us-gaap Operating Leases Future Minimum Payments Remainder Of Fiscal Year
OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear
322000
CY2018Q3 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
2039000
CY2018Q3 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
2321000
CY2018Q3 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
2391000
CY2018Q3 us-gaap Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
2463000
CY2018Q3 us-gaap Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
6709000
CY2017Q4 us-gaap Purchase Obligation
PurchaseObligation
0
CY2018Q2 vray Preferred Stock Conversion Percentage
PreferredStockConversionPercentage
1
vray Class Of Warrant Or Right Exercised
ClassOfWarrantOrRightExercised
44183
CY2018Q3 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
3022581
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
969783
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Additional Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized
8326158
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
5716505
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
801933
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
1767542
CY2018Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
2613827
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
8592747
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
1607108
CY2018Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
11900211
CY2018Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
4731731
CY2018Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
11397852
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
3.69
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
8.66
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
2.22
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
6.00
CY2018Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
6.12
CY2018Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
3.57
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P5Y1M6D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
P7Y2M12D
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
47864000
CY2018Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
27404000
CY2018Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
38576000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
5.02
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
4300000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
11600000
CY2018Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
28900000
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P3Y3M18D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.604
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.028
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
20109
CY2018Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
1747433
CY2018Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
1878322
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
9.65
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
10.31
CY2018Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
9.64
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2018Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
7179000
CY2017Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
984000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
10052000
CY2018Q3 us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
0
us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
0
CY2017Q3 us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
0
us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
0
CY2017 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.35
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.22
CY2018Q3 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
1500000
CY2017Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
1100000
us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
0
CY2017 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
0
CY2018Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
17922161
CY2017Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
11621439
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
15541124
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
11167721

Files In Submission

Name View Source Status
0001564590-18-028764-index-headers.html Edgar Link pending
0001564590-18-028764-index.html Edgar Link pending
0001564590-18-028764.txt Edgar Link pending
0001564590-18-028764-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
vray-10q_20180930.htm Edgar Link pending
vray-20180930.xml Edgar Link completed
vray-20180930.xsd Edgar Link pending
vray-20180930_cal.xml Edgar Link unprocessable
vray-20180930_def.xml Edgar Link unprocessable
vray-20180930_lab.xml Edgar Link unprocessable
vray-20180930_pre.xml Edgar Link unprocessable
vray-ex311_8.htm Edgar Link pending
vray-ex312_6.htm Edgar Link pending
vray-ex321_11.htm Edgar Link pending